Dexmethylphenidate


Dexmethylphenidate, sold under the brand name Focalin among others, is a medication used to treat attention deficit hyperactivity disorder in those over the age of 5 years. If no benefit is seen after 4 weeks it is reasonable to discontinue its use. It is taken by mouth. The immediate release formulation lasts up to 5 hours while the extended release formulation lasts up to 12 hours.
Common side effects include abdominal pain, loss of appetite, and fever. Serious side effects may include abuse, psychosis, sudden cardiac death, mania, anaphylaxis, seizures, and dangerously prolonged erection. Safety during pregnancy and breastfeeding is unclear. Dexmethylphenidate is a central nervous system stimulant. How it works in ADHD is unclear. It is the more active enantiomer of methylphenidate.
Dexmethylphenidate was approved for medical use in the United States in 2001. It is available as a generic medication. The wholesale cost of a month supply in the United States is about US$8. In 2017, it was the 189th most commonly prescribed medication in the United States, with more than three million prescriptions. It is also available in Switzerland.

Medical uses

Dexmethylphenidate is used as a treatment for ADHD, usually along with psychological, educational, behavioral or other forms of treatment. It is proposed that stimulants help ameliorate the symptoms of ADHD by making it easier for the user to concentrate, avoid distraction, and control behavior. Placebo-controlled trials have shown that once-daily dexmethylphenidate XR was effective and generally well tolerated.
Improvements in ADHD symptoms in children were significantly greater for dexmethylphenidate XR versus placebo. It also showed greater efficacy than osmotic controlled-release oral delivery system methylphenidate over the first half of the laboratory classroom day but assessments late in the day favoured OROS methylphenidate.

Contraindications

Adverse effects

Products containing dexmethylphenidate have a side effect profile comparable to those containing methylphenidate.

Overdose

Interactions

Mode of activity

Methylphenidate is a catecholamine reuptake inhibitor that indirectly increases catecholaminergic neurotransmission by inhibiting the dopamine transporter and norepinephrine transporter, which are responsible for clearing catecholamines from the synapse, particularly in the striatum and meso-limbic system. Moreover, it is thought to "increase the release of these monoamines into the extraneuronal space."
Although four stereoisomers of methylphenidate are possible, only the threo diastereoisomers are used in modern practice. There is a high eudysmic ratio between the SS and RR enantiomers of MPH. Dexmethylphenidate is a preparation of the RR enantiomer of methylphenidate. In theory, D-TMP can be anticipated to be twice the strength of the racemic product.
CompdDAT DA NET NE
D-TMP1612320639
L-TMP22501600>10K980
DL-TMP1212078851

Pharmacology

Dexmethylphenidate has a 4–6 hour duration of effect -TMP XR It has also been demonstrated to reduce ADHD symptoms in both children and adults. d-MPH has a similar side-effect profile to MPH and can be administered without regard to food intake.